Osiris Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (25)

Latest Posts

About This Stock More About This Stock
Premarket Biotech Digest | Sector News Brief
Article By: KKD Healthcare Analytics
Thursday, January 21, 2016 3:12 AM EDT
The sector news section of our extended daily premarket digest publication.
In this article: JNJ, TBIO, CASI, AKRX, OSIR, XON, MBVX, GLPG, SMMT
Read
The Medicines Co.'s New Minocin Formulation Approved
Article By: Zacks Investment Research
Monday, April 20, 2015 5:56 PM EDT
The Medicines Company gained FDA approval for its supplemental new drug application for a new formulation of Minocin. However, there are other stocks within the health care sector which are more deserving of investors attention.
In this article: MDCO, AVEO, OSIR, HZNP
Read
U.S. Stocks Switched Between Small Gains And Losses
Article By: BioMedReports
Friday, November 7, 2014 4:36 PM EDT
With the main benchmarks hovering near record levels in the wake of a solid jobs report, a key payrolls data showed the economy added 214,000 jobs in October, while the unemployment rate ticked down to 5.8% — a broadly positive reading.
In this article: HGR, ISIS, OSIR, RPRX, MDRX
Read
Regeneron And Sanofi Reported Positive Top-Line Results Of Alirocumab For Hypercholesterolemia Treatment
Article By: Dr. Hung Tran
Wednesday, July 30, 2014 3:36 PM EDT
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)’s shares soared as much as $20.62, hitting $325.13, or 6.77 percent as the company received one good news after the next.
In this article: SNY, OSIR, REGN
Read
Regeneron Pharmaceuticals' Shares Predicted To Rise Tomorrow With FDA Approval Of EYLEA
Article By: Dr. Hung Tran
Wednesday, July 30, 2014 8:27 AM EDT
Regeneron’s shares are predicted to rise tomorrow as the company received the FDA approval of EYLEA (aflibercept) injection for the treatment of diabetic macular edema (DME) – a common complication in the eyes of diabetic patients.
In this article: OSIR, REGN
Read

PARTNER HEADLINES

Latest Tweets for $OSIR

No tweets yet!